The authors have designated this AOP as all rights reserved. Re-use in any form requires advanced permission from the authors.

AOP: 569

Title

A descriptive phrase which references both the Molecular Initiating Event and Adverse Outcome.It should take the form “MIE leading to AO”. For example, “Aromatase inhibition leading to reproductive dysfunction” where Aromatase inhibition is the MIE and reproductive dysfunction the AO. In cases where the MIE is unknown or undefined, the earliest known KE in the chain (i.e., furthest upstream) should be used in lieu of the MIE and it should be made clear that the stated event is a KE and not the MIE.  More help

Decreased DNA methylation of FAM50B/PTCHD3 leading to IQ loss of children via PI3K-Akt pathway

Short name
A name that succinctly summarises the information from the title. This name should not exceed 90 characters. More help
DNA methylation of FAM50B/PTCHD3 and IQ loss of children
The current version of the Developer's Handbook will be automatically populated into the Handbook Version field when a new AOP page is created.Authors have the option to switch to a newer (but not older) Handbook version any time thereafter. More help
Handbook Version v2.7

Graphical Representation

A graphical representation of the AOP.This graphic should list all KEs in sequence, including the MIE (if known) and AO, and the pair-wise relationships (links or KERs) between those KEs. More help
Click to download graphical representation template Explore AOP in a Third Party Tool

Authors

The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. More help

Cong Wana, b, Huimin Maa, b*, Guanghui Dongc, Xiaowen Zengc, Kevin C. Jonesd, Gan Zhanga, b, Zhiqiang Yua, b, Pingan Penga, b

a State Key Laboratory of Advanced Environmental Technology and Guangdong Province Key Laboratory of Environmental Protection and Resources Utilization, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, Guangzhou 510640, China;

bGuangdong-Hong Kong-Macao Joint Laboratory for Environmental Pollution and Control, Guangzhou 510640, China;

cDepartment of Preventive Medicine, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China;

dLancaster Environmental Centre, Lancaster University, LA1 4YQ Lancaster, United Kingdom

Point of Contact

The user responsible for managing the AOP entry in the AOP-KB and controlling write access to the page by defining the contributors as described in the next section.   More help
Huimin Ma   (email point of contact)

Contributors

Users with write access to the AOP page.  Entries in this field are controlled by the Point of Contact. More help
  • Huimin Ma
  • Cong Wan

Coaches

This field is used to identify coaches who supported the development of the AOP.Each coach selected must be a registered author. More help

OECD Information Table

Provides users with information concerning how actively the AOP page is being developed and whether it is part of the OECD Workplan and has been reviewed and/or endorsed. OECD Project: Assigned upon acceptance onto OECD workplan. This project ID is managed and updated (if needed) by the OECD. OECD Status: For AOPs included on the OECD workplan, ‘OECD status’ tracks the level of review/endorsement of the AOP . This designation is managed and updated by the OECD. Journal-format Article: The OECD is developing co-operation with Scientific Journals for the review and publication of AOPs, via the signature of a Memorandum of Understanding. When the scientific review of an AOP is conducted by these Journals, the journal review panel will review the content of the Wiki. In addition, the Journal may ask the AOP authors to develop a separate manuscript (i.e. Journal Format Article) using a format determined by the Journal for Journal publication. In that case, the journal review panel will be required to review both the Wiki content and the Journal Format Article. The Journal will publish the AOP reviewed through the Journal Format Article. OECD iLibrary published version: OECD iLibrary is the online library of the OECD. The version of the AOP that is published there has been endorsed by the OECD. The purpose of publication on iLibrary is to provide a stable version over time, i.e. the version which has been reviewed and revised based on the outcome of the review. AOPs are viewed as living documents and may continue to evolve on the AOP-Wiki after their OECD endorsement and publication.   More help
OECD Project # OECD Status Reviewer's Reports Journal-format Article OECD iLibrary Published Version
This AOP was last modified on May 22, 2025 11:43

Revision dates for related pages

Page Revision Date/Time
Decreased DNA methylation of FAM50B/PTCHD3 March 02, 2025 09:26
Elevated gene expression of FAM50B/PTCHD3 March 02, 2025 09:28
Inhibition of PI3K-Akt pathway March 02, 2025 09:32
Increase, CNS Neural cell death October 17, 2023 04:07
decreased, Intellectual Quotient May 29, 2025 12:51
Increase, Reactive oxygen species June 12, 2025 01:27
FAM50B/PTCHD3 methylation leads to FAM50B/PTCHD3 expression March 02, 2025 09:37
FAM50B/PTCHD3 methylation leads to decreased, IQ March 02, 2025 09:41
FAM50B/PTCHD3 expression leads to PI3K-Akt pathway March 02, 2025 09:38
PI3K-Akt pathway leads to Increase, ROS May 22, 2025 11:32
Increase, ROS leads to Increase, CNS Neural cell death May 22, 2025 11:32
Increase, CNS Neural cell death leads to decreased, IQ March 02, 2025 09:40

Abstract

A concise and informative summation of the AOP under development that can stand-alone from the AOP page. The aim is to capture the highlights of the AOP and its potential scientific and regulatory relevance. More help

Intelligence quotient (IQ) test scores are important endpoints for international agencies interested in protecting the brain health from heavy metal exposure. However, IQ test has been hampered by a lack of efficient tools. At present, IQ test is mainly relied on Wechsler Intelligence Assessment Scale, this method consumes a lot of manpower and material resources, and cannot achieve high throughput assessment. The motivation for developing this adverse outcome pathway (AOP) was to provide new method for IQ assessment by DNA methylation in a high throughput way. In this AOP, the decreased DNA methylation of FAM50B and PTCHD3 induced by heavy metal exposure (such as lead, arsenic, and so on) is the molecular initiating event (MIE) of this AOP. Decreased DNA methylation of FAM50B/PTCHD3 leads to the elevated gene expression of FAM50B/PTCHD3, which is one of the key events (KE) of molecular level. This KE leads to the inhibition of PI3K-Akt pathway, which is another KE of molecular level, leading to increased celluar ROS and cell death (two KEs of cell level). These KEs finally result in the IQ loss of children (the adverse outcome of individual level).

AOP Development Strategy

Context

Used to provide background information for AOP reviewers and users that is considered helpful in understanding the biology underlying the AOP and the motivation for its development.The background should NOT provide an overview of the AOP, its KEs or KERs, which are captured in more detail below. More help

Although global lead exposure has significantly declined since the phase-out of leaded gasoline, it remains a pervasive issue, particularly in low- and middle-income countries (Larsen et al., 2023; Li et al., 2014). A report by The Lancet points out that there are still 815 million (One third of global children) children worldwide with blood lead concentrations exceeding 50 μg/L (Burki et al., 2020). DNA methylation is an important bridge to link environmental pollutants and adverse outcomes. FAM50B has relatively high expression in human brain (https://tissues.jensenlab.org). We screened two genes (FAM50B and PTCHD3) that mediated lead exposure and children's IQ and neurodevelopment through multiple epidemiological studies, and FAM50B/PTCHD3 methylation had good quantitative relationships with chidren's IQ and neurodevelopment (Wan et al., 2021; 2024). The identified FAM50B/PTCHD3 DNA methylation biomarkers could aid in developing early diagnostic tools and targeted treatments for neurodevelopmental disorders, as well as in quantitative environmental health risk assessments for heavy metals.   

Strategy

Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components.  Suggested content includes a rationale for and description of the scope and focus of the data search and identification strategy/ies including the nature of preliminary scoping and/or expert input, the overall literature screening strategy and more focused literature surveys to identify additional information (including e.g., key search terms, databases and time period searched, any tools used). More help

In this study, the concentrations of blood heavy metals such as lead was detected by ICP-MS. Children's IQ was tested by Wechsler and Raven Intelligence Test. Blood DNA was purified to detect genome DNA methylation and screen differentially methylated regions (DMRs). The gene expression of FAM50B/PTCHD3 was determined by RT-PCR. The protein expression of PI3K-Akt pathway was assessed by western-blotting. In addition, cell ROS and apoptosis were detected by flow cytometry. The quantitative relationships between FAM50B/PTCHD3 methylation and children's IQ was constructed by machine learning.

Summary of the AOP

This section is for information that describes the overall AOP.The information described in section 1 is entered on the upper portion of an AOP page within the AOP-Wiki. This is where some background information may be provided, the structure of the AOP is described, and the KEs and KERs are listed. More help

Events:

Molecular Initiating Events (MIE)
An MIE is a specialised KE that represents the beginning (point of interaction between a prototypical stressor and the biological system) of an AOP. More help
Key Events (KE)
A measurable event within a specific biological level of organisation. More help
Adverse Outcomes (AO)
An AO is a specialized KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help
Type Event ID Title Short name
MIE 2309 Decreased DNA methylation of FAM50B/PTCHD3 FAM50B/PTCHD3 methylation
KE 2310 Elevated gene expression of FAM50B/PTCHD3 FAM50B/PTCHD3 expression
KE 2311 Inhibition of PI3K-Akt pathway PI3K-Akt pathway
KE 1115 Increase, Reactive oxygen species Increase, ROS
KE 2195 Increase, CNS Neural cell death Increase, CNS Neural cell death
AO 2121 decreased, Intellectual Quotient decreased, IQ

Relationships Between Two Key Events (Including MIEs and AOs)

This table summarizes all of the KERs of the AOP and is populated in the AOP-Wiki as KERs are added to the AOP.Each table entry acts as a link to the individual KER description page. More help

Network View

This network graphic is automatically generated based on the information provided in the MIE(s), KEs, AO(s), KERs and Weight of Evidence (WoE) summary tables. The width of the edges representing the KERs is determined by its WoE confidence level, with thicker lines representing higher degrees of confidence. This network view also shows which KEs are shared with other AOPs. More help

Prototypical Stressors

A structured data field that can be used to identify one or more “prototypical” stressors that act through this AOP. Prototypical stressors are stressors for which responses at multiple key events have been well documented. More help

Life Stage Applicability

The life stage for which the AOP is known to be applicable. More help

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available. More help

Sex Applicability

The sex for which the AOP is known to be applicable. More help

Overall Assessment of the AOP

Addressess the relevant biological domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and Weight of Evidence (WoE) for the overall AOP as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). More help

Domain of Applicability

Addressess the relevant biological domain(s) of applicability in terms of sex, life-stage, taxa, and other aspects of biological context. More help

Essentiality of the Key Events

The essentiality of KEs can only be assessed relative to the impact of manipulation of a given KE (e.g., experimentally blocking or exacerbating the event) on the downstream sequence of KEs defined for the AOP. Consequently, evidence supporting essentiality is assembled on the AOP page, rather than on the independent KE pages that are meant to stand-alone as modular units without reference to other KEs in the sequence. The nature of experimental evidence that is relevant to assessing essentiality relates to the impact on downstream KEs and the AO if upstream KEs are prevented or modified. This includes: Direct evidence: directly measured experimental support that blocking or preventing a KE prevents or impacts downstream KEs in the pathway in the expected fashion. Indirect evidence: evidence that modulation or attenuation in the magnitude of impact on a specific KE (increased effect or decreased effect) is associated with corresponding changes (increases or decreases) in the magnitude or frequency of one or more downstream KEs. More help

Evidence Assessment

Addressess the biological plausibility, empirical support, and quantitative understanding from each KER in an AOP. More help

Known Modulating Factors

Modulating factors (MFs) may alter the shape of the response-response function that describes the quantitative relationship between two KES, thus having an impact on the progression of the pathway or the severity of the AO.The evidence supporting the influence of various modulating factors is assembled within the individual KERs. More help
Modulating Factor (MF) Influence or Outcome KER(s) involved
     

Quantitative Understanding

Optional field to provide quantitative weight of evidence descriptors.  More help

Considerations for Potential Applications of the AOP (optional)

Addressess potential applications of an AOP to support regulatory decision-making.This may include, for example, possible utility for test guideline development or refinement, development of integrated testing and assessment approaches, development of (Q)SARs / or chemical profilers to facilitate the grouping of chemicals for subsequent read-across, screening level hazard assessments or even risk assessment. More help

References

List of the literature that was cited for this AOP. More help

Larsen, B.; Sánchez-Triana, E. Global health burden and cost of lead exposure in children and adults: a health impact and economic modelling analysis. Lancet Planet Health 2023, 7 (10), e831-e840.

Li, M. M.; Cao, J.; Xu, J.; Cai, S. Z.; Shen, X. M.; Yan, C. H. The national trend of blood lead levels among Chinese children aged 0-18 years old, 1990-2012. Environ Int 2014, 71, 109-117.

Wan, C.; Ma, H.; Liu, J.; Liu, F.; Liu, J.; Dong, G.; Zeng, X.; Li, D.; Yu, Z.; Wang, X.; et al. Quantitative relationships of FAM50B and PTCHD3 methylation with reduced intelligence quotients in school aged children exposed to lead: Evidence from epidemiological and in vitro studies. Sci Total Environ 2024, 907, 167976.

Wan, C.; Pan, S.; Lin, L.; Li, J.; Dong, G.; Jones, K. C.; Liu, F.; Li, D.; Liu, J.; Yu, Z.; et al. DNA Methylation Biomarkers of IQ Reduction are Associated with Long-term Lead Exposure in School Aged Children in Southern China. Environ. Sci. Technol. 2021, 55 (1), 412-422.